Liana Barenbrug
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Current Evidence on IL-17 and IL-(12)/23 Inhibitor Safety during Pregnancy in Psoriasis: A Call for Harmonized Data Collection.
Journal: Acta dermato-venereologica
Published: June 16, 2026
Family planning and pregnancy among patients with psoriasis: incorporating the patients' voice in healthcare practice and information provision.
Journal: The Journal of dermatological treatment
Published: July 31, 2025
Sex-disparities in pediatric and young adult patients with psoriasis treated with biologics: differences in adverse events and disease activity.
Journal: The Journal of dermatological treatment
Published: July 23, 2025
Lower Drug Survival, Less Satisfaction and More Adverse Events in Females Using Biologics for Psoriasis: Results of the Dutch BioCAPTURE Registry.
Journal: Journal of psoriasis and psoriatic arthritis
Published: December 13, 2024
Understanding the role of immune-mediated inflammatory disease related cytokines interleukin 17 and 23 in pregnancy: A systematic review.
Journal: Journal of translational autoimmunity
Published: December 11, 2024
Drug Survival of IL-17 and IL-23 Inhibitors for Psoriasis: A Systematic Review and Meta-Analysis.
Journal: Drugs
Published: March 25, 2024
Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis.
Journal: Journal of autoimmunity
Published: March 23, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026